# MIST (Milestone Pharmaceuticals Inc.) - SEC EDGAR Financial Statements

> Milestone Pharmaceuticals Inc. reported $162.7M in total assets and a net loss of $97.89M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MIST
- Markdown: https://convexityos.com/fundamentals/MIST.md
- SEC CIK: 0001408443
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001408443&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$91.60M | Operating profit |
| Net Income | FY 2025 | -$97.89M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.75 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$77.14M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $145.4M | Total debt: $60.94M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $18.11M | $14.36M | $31.05M | $39.83M | $38.67M | $34.49M | $41.98M | $16.85M |
| **Operating Income** | -$62.14M | -$42.10M | -$61.10M | -$59.64M | -$43.07M | -$50.71M | -$57.88M | -$23.82M |
| **EBITDA** | -$62.03M | -$42.00M | -$61.01M | -$59.55M | -$42.98M | -$50.61M | -$57.84M | -$23.81M |
| Interest Income | $2.92M | $4.16M | $3.97M | -- | -- | -- | -- | -- |
| Interest Expense | $3.84M | $3.58M | $2.55M | -- | -- | -- | -- | -- |
| Income Before Tax | -$63.06M | -$41.52M | -$59.69M | -$58.39M | -$42.85M | -$49.98M | -$55.28M | -$23.11M |
| Income Tax Expense | -- | -- | -- | -- | -- | -$17K | -$56K | $74K |
| **Net Income** | -$63.06M | -$41.52M | -$59.69M | -$58.39M | -$42.85M | -$49.97M | -$55.23M | -$23.18M |
| Basic EPS | -$0.75 | -$0.67 | -$1.39 | -$1.38 | -$1.02 | -$1.70 | -$3.50 | $72.63 |
| **Diluted EPS** | -$0.75 | -$0.67 | -$1.39 | -$1.38 | -$1.02 | -$1.70 | -$3.50 | $72.63 |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | 29.3M | 15.8M | 319.2K |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | 29.3M | 15.8M | 319.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.96M | $559K | $238K | -- | $0 | $0 | $0 | -- |
| Cost of Revenue | $325K | $32K | $14K | -- | $0 | $0 | $0 | -- |
| **Gross Profit** | $2.64M | $527K | $224K | -- | $0 | $0 | $0 | -- |
| Research & Development | $3.46M | $3.51M | $3.25M | $5.52M | $3.94M | $3.67M | $4.98M | $3.94M |
| Selling, General & Admin | $24.23M | $22.65M | -- | -- | $7.89M | $8.86M | -- | -- |
| **Operating Income** | -$25.05M | -$25.63M | -$23.66M | -$17.26M | -$11.83M | -$12.53M | -$20.52M | -$12.35M |
| **EBITDA** | -$25.00M | -$25.57M | -$23.61M | -$17.22M | -$11.80M | -$12.50M | -$20.50M | -$12.32M |
| Interest Income | $1.44M | $1.74M | $1.73M | $833K | $874K | $516K | $697K | $904K |
| Interest Expense | $2.18M | $4.72M | $4.13M | $985K | $967K | $951K | $935K | $919K |
| **Net Income** | -$25.80M | -$28.61M | -$26.07M | -$17.41M | -$11.92M | -$12.97M | -$20.76M | -$12.36M |
| Basic EPS | -$0.18 | -$0.21 | -$0.20 | -- | -$0.12 | -$0.20 | -$0.31 | -- |
| **Diluted EPS** | -$0.18 | -$0.21 | -$0.20 | -- | -$0.12 | -$0.20 | -$0.31 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $73.05M | $25.31M | $13.76M | $7.64M | $114.1M | $72.31M | $119.8M | $85.95M |
| Short-Term Investments | $32.91M | $44.38M | $52.24M | $56.95M | $0 | $70.00M | -- | $29K |
| **Cash & Short-Term Investments** | $106.0M | $69.70M | $66.00M | $64.50M | $114.1M | $142.3M | $119.8M | $85.98M |
| Inventory | $648K | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $111.9M | $73.93M | $73.03M | $71.80M | $118.9M | $148.7M | $122.5M | $88.05M |
| Property, Plant & Equipment, Net | $511K | $197K | $277K | $257K | $215K | $308K | $405K | $30K |
| **Total Non-Current Assets** | $1.64M | $1.57M | $2.19M | $2.68M | $926K | $1.29M | $929K | $30K |
| **Total Assets** | $113.6M | $75.50M | $75.23M | $74.48M | $119.8M | $150.0M | $123.4M | $88.08M |
| Accounts Payable | $5.64M | $1.93M | $3.98M | $2.26M | $4.38M | $4.64M | $4.38M | $2.60M |
| Other Current Liabilities | $43K | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $13.98M | $8.13M | $7.23M | $6.14M | $6.78M | $6.16M | $8.33M | $4.53M |
| Long-Term Debt | $57.19M | $53.35M | $49.77M | -- | -- | -- | $0 | -- |
| Other Non-Current Liabilities | $83K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $57.81M | $54.23M | $51.23M | $2.00M | $474K | $696K | $184K | $0 |
| **Total Liabilities** | $71.79M | $62.35M | $58.45M | $8.13M | $7.25M | $6.86M | $8.51M | $4.53M |
| **Total Debt (incl. Leases)** | $58.38M | $54.80M | $51.77M | $2.49M | $687K | $942K | $514K | -- |
| Common Stock | $352.6M | $288.0M | $260.5M | $273.9M | $251.9M | $251.7M | $226.2M | $2.04M |
| Retained Earnings | -$430.6M | -$367.5M | -$326.0M | -$266.3M | -$208.0M | -$163.5M | -$113.5M | -$58.27M |
| **Total Stockholders' Equity** | $41.77M | $13.15M | $16.77M | $66.35M | $112.6M | $143.1M | $114.9M | $83.55M |
| Total Equity | $41.77M | $13.15M | $16.77M | $66.35M | $112.6M | $143.1M | $114.9M | -$55.21M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $144.5M | $169.7M | $71.32M | $73.05M | $46.69M | $42.50M | $45.09M | $25.31M |
| Short-Term Investments | $882K | $881K | $112.9M | $32.91M | $35.90M | $918K | $10.87M | $44.38M |
| **Cash & Short-Term Investments** | $145.4M | $170.6M | $184.2M | $106.0M | $82.60M | $43.40M | $56.00M | $69.70M |
| Accounts Receivable, Net | $3.93M | $2.72M | $1.60M | -- | -- | -- | -- | -- |
| Inventory | $6.68M | $4.72M | $1.83M | $648K | -- | -- | -- | -- |
| **Total Current Assets** | $161.6M | $180.3M | $192.3M | $111.9M | $86.67M | $46.17M | $60.48M | $73.93M |
| Property, Plant & Equipment, Net | $416K | $469K | $500K | $511K | $136K | $159K | $176K | $197K |
| **Total Non-Current Assets** | $1.09M | $1.30M | $1.48M | $1.64M | $1.08M | $1.25M | $1.41M | $1.57M |
| **Total Assets** | $162.7M | $181.6M | $193.7M | $113.6M | $87.75M | $47.42M | $61.88M | $75.50M |
| Accounts Payable | $9.23M | $8.45M | $10.02M | $5.64M | $3.18M | $2.93M | $2.38M | $1.93M |
| Deferred Revenue (Current) | $1.32M | $1.03M | $416K | -- | -- | -- | -- | -- |
| Other Current Liabilities | $43K | $43K | $43K | $43K | -- | -- | -- | -- |
| **Total Current Liabilities** | $25.78M | $22.18M | $20.94M | $13.98M | $10.52M | $9.28M | $12.96M | $8.13M |
| Long-Term Debt | $60.24M | $59.21M | $58.19M | $57.19M | $56.21M | $55.24M | $54.29M | $53.35M |
| Other Non-Current Liabilities | $51K | $61K | $72K | $83K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $143.1M | $141.2M | $136.7M | $57.81M | $56.73M | $55.88M | $55.05M | $54.23M |
| **Total Liabilities** | $168.9M | $163.4M | $157.7M | $71.79M | $67.25M | $65.16M | $68.01M | $62.35M |
| **Total Debt (incl. Leases)** | $60.94M | $60.07M | $59.22M | $58.38M | $57.21M | $56.39M | $55.59M | $54.80M |
| Common Stock | $385.0M | $385.0M | $373.7M | $352.6M | $311.8M | $288.3M | $288.2M | $288.0M |
| Retained Earnings | -$511.1M | -$485.3M | -$456.7M | -$430.6M | -$413.2M | -$401.3M | -$388.3M | -$367.5M |
| **Total Stockholders' Equity** | -$6.22M | $18.22M | $36.05M | $41.77M | $20.50M | -$17.75M | -$6.12M | $13.15M |
| Total Equity | -$6.22M | $18.22M | $36.05M | $41.77M | $20.50M | -$17.75M | -$6.12M | $13.15M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$63.06M | -$41.52M | -$59.69M | -$58.39M | -$42.85M | -$49.97M | -$55.23M | -$23.18M |
| Depreciation & Amortization | $114K | $105K | $92K | $89K | $93K | $97K | $38K | $10K |
| Stock-Based Compensation | $7.46M | $5.78M | $9.53M | $9.05M | $7.28M | $4.95M | $1.19M | $633K |
| Change in Inventory | -$648K | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$49.04M | -$28.85M | -$46.42M | -$52.47M | -$33.22M | -$50.73M | -$51.15M | -$21.05M |
| Capital Expenditure | -$302K | -$33K | -$112K | -$272K | -- | -- | -$413K | -$5.0K |
| **Free Cash Flow** | -$49.34M | -$28.88M | -$46.54M | -$52.74M | -- | -- | -$51.56M | -$21.05M |
| **Investing Cash Flow** | $11.25M | $8.28M | $4.76M | -$57.12M | $70.00M | -$70.00M | -$384K | $16.00M |
| Common Stock Issued | $37.59M | $27.26M | -- | $2.63M | -- | $24.92M | -- | -- |
| **Financing Cash Flow** | $85.53M | $32.12M | $47.79M | $3.09M | $5.05M | $73.22M | $85.41M | $80.11M |
| **Net Change in Cash** | $47.73M | $11.55M | $6.12M | -$106.5M | $41.83M | -$47.51M | $33.87M | $75.07M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$25.80M | -$28.61M | -$26.07M | -$17.41M | -$11.92M | -$12.97M | -$20.76M | -$12.36M |
| Depreciation & Amortization | $57K | $57K | $56K | $34K | $25K | $28K | $27K | $26K |
| Stock-Based Compensation | $1.36M | $1.34M | $1.28M | $3.55M | $1.25M | $1.31M | $1.35M | $1.47M |
| Change in Receivables | -$1.21M | -$1.11M | -$1.60M | -- | -- | -- | -- | -- |
| Change in Inventory | -$1.95M | -$2.90M | -$1.18M | -- | -- | -- | -- | -- |
| Change in Payables | $781K | -$1.57M | $4.38M | -- | $255K | $544K | $452K | -- |
| **Operating Cash Flow** | -$25.24M | -$22.71M | -$16.05M | -$12.78M | -$9.75M | -$12.57M | -$13.95M | -$6.84M |
| Capital Expenditure | -$4.0K | -$26K | -$45K | -$283K | -$2.0K | -$11K | -$6.0K | -- |
| **Free Cash Flow** | -$25.25M | -$22.74M | -$16.10M | -$13.06M | -$9.75M | -$12.58M | -$13.96M | -- |
| **Investing Cash Flow** | -$5.0K | $112.0M | -$80.03M | $2.70M | -$34.98M | $9.94M | $33.58M | $19.33M |
| Common Stock Issued | $0 | $0 | $10.89M | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -$9.0K | $9.13M | $94.35M | $36.43M | $48.92M | $36K | $140K | $24K |
| **Net Change in Cash** | -$25.26M | $98.41M | -$1.73M | $26.36M | $4.19M | -$2.59M | $19.77M | $12.52M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -151.0% | -315.8% | -355.9% | -88.0% | -38.1% | -34.9% | -48.1% | -27.8% |
| Return on Assets (ROA) | -55.5% | -55.0% | -79.3% | -78.4% | -35.8% | -33.3% | -44.7% | -26.3% |
| Current Ratio | 8.01x | 9.10x | 10.11x | 11.70x | 17.55x | 24.14x | 14.71x | 19.42x |
| Quick Ratio | 7.96x | 8.58x | 9.13x | 10.51x | 16.84x | 23.10x | 14.39x | 18.97x |
| Debt to Equity | 1.40x | 4.17x | 3.09x | 0.04x | 0.01x | 0.01x | 0.00x | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -104.8% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -461.1% | -189.6% | -151.0% | -283.0% | -- | -- | -315.8% |
| Return on Assets (ROA) | -60.2% | -46.3% | -35.3% | -55.5% | -66.1% | -117.1% | -83.9% | -55.0% |
| Current Ratio | 6.27x | 8.13x | 9.18x | 8.01x | 8.24x | 4.97x | 4.67x | 9.10x |
| Quick Ratio | 6.01x | 7.92x | 9.09x | 7.96x | 7.85x | 4.68x | 4.32x | 8.58x |
| Debt to Equity | -- | 3.30x | 1.64x | 1.40x | 2.79x | -- | -- | 4.17x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
